OBD presents at The Scottish Early Rheumatoid Arthritis (SERA) Meeting in Perth, Scotland, the results of its Stage I development of EpiSwitch™ predictive biomarkers for Methotrexate treatment in RA.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.OkRead more
